Amedeo Smart

Free Medical Literature Service



HIV Infection

  Free Subscription


3 AIDS Res Hum Retroviruses
1 Antimicrob Agents Chemother
1 Arch Dis Child
1 Blood
2 BMC Cancer
1 HIV Med
1 Immunology
3 J Acquir Immune Defic Syndr
1 J Am Acad Dermatol
1 J Med Virol
1 J Neurosurg Pediatr
4 J Virol
3 Lancet
4 Lancet HIV
1 Nat Rev Neurol
1 Pediatr Infect Dis J
19 PLoS One
1 PLoS Pathog

    AIDS Res Hum Retroviruses

  1. TRAPECAR M, Khan S, Roan N, Chen TH, et al
    An Optimized and Validated Method for Isolation and Characterization of Lymphocytes from HIV+ Human Gut Biopsies.
    AIDS Res Hum Retroviruses. 2017 Sep 7. doi: 10.1089/AID.2017.0208.
    >> Share

  2. KIEFFER C, Ladinsky MS, Bjorkman PJ
    Multiscale imaging of HIV-1 transmission in humanized mice.
    AIDS Res Hum Retroviruses. 2017 Sep 7. doi: 10.1089/AID.2017.0142.
    >> Share

  3. KHAN S, Telwatte S, Trapecar M, Yukl S, et al
    Differentiating Immune Cell Targets in Gut-Associated Lymphoid Tissue for HIV Cure.
    AIDS Res Hum Retroviruses. 2017 Sep 7. doi: 10.1089/AID.2017.0153.
    >> Share

    Antimicrob Agents Chemother

  4. GARCIA-VIDAL E, Castellvi M, Pujantell M, Badia R, et al
    Evaluation of the innate immune modulator acitretin as a strategy to clear the HIV reservoir.
    Antimicrob Agents Chemother. 2017 Sep 5. pii: AAC.01368.
    >> Share

    Arch Dis Child

  5. SOKAL E, Nannini P
    Hepatitis C virus in children: the global picture.
    Arch Dis Child. 2017;102:672-675.
    >> Share


  6. ALVARNAS JC, Zaia JA, Forman SJ
    How I treat patients with HIV-related hematological malignancies using hematopoietic cell transplantation.
    Blood. 2017 Sep 7. pii: blood-2017-04-551606. doi: 10.1182/blood-2017-04-551606.
    >> Share

    BMC Cancer

  7. TOMOKA T, Powers E, van der Gronde T, Amuquandoh A, et al
    Extranodal natural killer/T-cell lymphoma in Malawi: a report of three cases.
    BMC Cancer. 2017;17:633.
    >> Share

  8. SEMEERE A, Freeman E, Wenger M, Glidden D, et al
    Updating vital status by tracking in the community among patients with epidemic Kaposi sarcoma who are lost to follow-up in sub-Saharan Africa.
    BMC Cancer. 2017;17:611.
    >> Share


  9. PANDA S, Swaminathan S, Hyder KA, Christophel EM, et al
    Drug resistance in malaria, tuberculosis, and HIV in South East Asia: biology, programme, and policy considerations.
    BMJ. 2017;358:j3545.
    >> Share

    HIV Med

  10. GERETTI AM, Loutfy M, D'Arminio Monforte A, Latysheva I, et al
    Out of focus: tailoring the cascade of care to the needs of women living with HIV.
    HIV Med. 2017;18 Suppl 2:3-17.
    >> Share


  11. KOLENBRANDER A, Grewe B, Nemazee D, Uberla K, et al
    Generation of T-follicular helper cells in vitro: requirement for BCR cross-linking and cognate B- and T-cell interaction.
    Immunology. 2017 Sep 7. doi: 10.1111/imm.12834.
    >> Share

    J Acquir Immune Defic Syndr

  12. TRAM KH, Mwangwa F, Atukunda M, Owaraganise A, et al
    Isoniazid Preventive Therapy Completion in the Era of Differentiated HIV Care.
    J Acquir Immune Defic Syndr. 2017 Sep 6. doi: 10.1097/QAI.0000000000001540.
    >> Share

  13. RICE WS, Burnham K, Mugavero MJ, Raper JL, et al
    Association between Internalized HIV-related Stigma and HIV Care Visit Adherence.
    J Acquir Immune Defic Syndr. 2017 Sep 6. doi: 10.1097/QAI.0000000000001543.
    >> Share

  14. MOORE DM, Cui Z, Lachowsky NJ, Rich AJ, et al
    Increasing HIV treatment optimism but no changes in HIV risk behaviour among men who have sex with men (MSM) in Vancouver, Canada.
    J Acquir Immune Defic Syndr. 2017 Sep 6. doi: 10.1097/QAI.0000000000001542.
    >> Share

    J Am Acad Dermatol

  15. BREWER JD, Elston DM, Vidimos AT, Rizza SA, et al
    Managing sharps injuries and other occupational exposures to HIV, HBV, and HCV in the dermatology office.
    J Am Acad Dermatol. 2017 Aug 30. pii: S0190-9622(17)31942.
    >> Share

    J Med Virol

  16. CAVARETTO LDSP, Motta-Castro ARC, Teles SA, de Souza FQ, et al
    Epidemiological and molecular analysis of hepatitis B virus infection in manicurists in Central Brazil.
    J Med Virol. 2017 Sep 8. doi: 10.1002/jmv.24940.
    >> Share

    J Neurosurg Pediatr

  17. SANTOS MM, Rubagumya DK, Dominic I, Brighton A, et al
    Infant hydrocephalus in sub-Saharan Africa: the reality on the Tanzanian side of the lake.
    J Neurosurg Pediatr. 2017 Sep 8:1-9. doi: 10.3171/2017.5.PEDS1755.
    >> Share

    J Virol

  18. SULLIVAN JT, Sulli C, Nilo A, Yasmeen A, et al
    High-throughput Protein Engineering Improves the Antigenicity and Stability of Soluble HIV-1 Envelope Glycoprotein SOSIP Trimers.
    J Virol. 2017 Sep 6. pii: JVI.00862-17. doi: 10.1128/JVI.00862.
    >> Share

  19. RIZK MG, Basler CF, Guatelli J
    Cooperation of the Ebola proteins VP40 and GP1,2 with BST2 to activate NF-kappabeta independently of virus-like particle trapping.
    J Virol. 2017 Sep 6. pii: JVI.01308-17. doi: 10.1128/JVI.01308.
    >> Share

  20. DE BOER RJ, Perelson AS
    How germinal centers evolve broadly neutralizing antibodies: the breadth of the follicular helper T cell response.
    J Virol. 2017 Sep 6. pii: JVI.00983-17. doi: 10.1128/JVI.00983.
    >> Share

  21. LEITMAN EM, Willberg CB, Tsai MH, Chen H, et al
    J Virol. 2017 Sep 6. pii: JVI.00544-17. doi: 10.1128/JVI.00544.
    >> Share


  22. GALLANT J, Lazzarin A, Mills A, Orkin C, et al
    Bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir, abacavir, and lamivudine for initial treatment of HIV-1 infection (GS-US-380-1489): a double-blind, multicentre, phase 3, randomised controlled non-inferiority trial.
    Lancet. 2017 Aug 31. pii: S0140-6736(17)32299.
    >> Share

  23. BOFFITO M, Venter F
    The triumph of HIV treatment: another new antiretroviral.
    Lancet. 2017 Aug 31. pii: S0140-6736(17)32297.
    >> Share

  24. SAX PE, Pozniak A, Montes ML, Koenig E, et al
    Coformulated bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir with emtricitabine and tenofovir alafenamide, for initial treatment of HIV-1 infection (GS-US-380-1490): a randomised, double-blind, multicentre, phase 3, non-infer
    Lancet. 2017 Aug 31. pii: S0140-6736(17)32340.
    >> Share

    Lancet HIV

    Divergent paths to the end of AIDS.
    Lancet HIV. 2017;4:e375.
    >> Share

  26. MAYER KH
    Optimism and concern at IAS 2017.
    Lancet HIV. 2017;4:e382-e383.
    >> Share

  27. WU Z, Tang Z, Mao Y, Van Veldhuisen P, et al
    Testing and linkage to HIV care in China: a cluster-randomised trial.
    Lancet HIV. 2017 Aug 31. pii: S2352-3018(17)30131.
    >> Share

    Control of HIV epidemic: improve access to testing and ART.
    Lancet HIV. 2017 Aug 31. pii: S2352-3018(17)30166.
    >> Share

    Nat Rev Neurol

  29. WILKINSON RJ, Rohlwink U, Misra UK, van Crevel R, et al
    Tuberculous meningitis.
    Nat Rev Neurol. 2017 Sep 8. doi: 10.1038/nrneurol.2017.
    >> Share

    Pediatr Infect Dis J

  30. HORMI M, Khourouj VG, Pommelet V, Jeljeli M, et al
    Performance of the QuantiFERON-TB Gold Assay Among HIV-infected Children with Active Tuberculosis in France.
    Pediatr Infect Dis J. 2017 Sep 5. doi: 10.1097/INF.0000000000001774.
    >> Share

    PLoS One

  31. MATTHEWS LT, Burns BF, Bajunirwe F, Kabakyenga J, et al
    Beyond HIV-serodiscordance: Partnership communication dynamics that affect engagement in safer conception care.
    PLoS One. 2017;12:e0183131.
    >> Share

  32. NYAOKE BA, Mutua GN, Sajabi R, Nyasani D, et al
    Volunteer motivators for participating in HIV vaccine clinical trials in Nairobi, Kenya.
    PLoS One. 2017;12:e0183788.
    >> Share

  33. BELLO G, Faragher B, Sanudi L, Namakhoma I, et al
    The effect of engaging unpaid informal providers on case detection and treatment initiation rates for TB and HIV in rural Malawi (Triage Plus): A cluster randomised health system intervention trial.
    PLoS One. 2017;12:e0183312.
    >> Share

  34. RICK F, Niyibizi AA, Shroufi A, Onami K, et al
    Cryptococcal antigen screening by lay cadres using a rapid test at the point of care: A feasibility study in rural Lesotho.
    PLoS One. 2017;12:e0183656.
    >> Share

  35. DUFFY D, Mottez E, Ainsworth S, Buivan TP, et al
    An in vitro diagnostic certified point of care single nucleotide test for IL28B polymorphisms.
    PLoS One. 2017;12:e0183084.
    >> Share

  36. LE NK, Riggi E, Marrone G, Vu TV, et al
    Assessment of WHO criteria for identifying ART treatment failure in Vietnam from 2007 to 2011.
    PLoS One. 2017;12:e0182688.
    >> Share

  37. RUGGLES KV, Patel AR, Schensul S, Schensul J, et al
    Betting on the fastest horse: Using computer simulation to design a combination HIV intervention for future projects in Maharashtra, India.
    PLoS One. 2017;12:e0184179.
    >> Share

  38. SAITO H, Takeuchi H, Masuda T, Noda T, et al
    N-terminally truncated POM121C inhibits HIV-1 replication.
    PLoS One. 2017;12:e0182434.
    >> Share

  39. BAILEY RC, Adera F, Mackesy-Amiti ME, Adipo T, et al
    Prospective comparison of two models of integrating early infant male circumcision with maternal child health services in Kenya: The Mtoto Msafi Mbili Study.
    PLoS One. 2017;12:e0184170.
    >> Share

  40. YANG S, Yang C, Liao Q, Zhai W, et al
    Analysis of HIV prevalence among pregnant women in Liangshan Prefecture, China, from 2009 to 2015.
    PLoS One. 2017;12:e0183418.
    >> Share

  41. GALLAY PA, Chatterji U, Kirchhoff A, Gandarilla A, et al
    Prevention of vaginal and rectal HIV transmission by antiretroviral combinations in humanized mice.
    PLoS One. 2017;12:e0184303.
    >> Share

  42. BALABAN CL, Banchio C, Ceccarelli EA
    TAT-mediated transduction of bacterial redox proteins generates a cytoprotective effect on neuronal cells.
    PLoS One. 2017;12:e0184617.
    >> Share

  43. PETOUMENOS K, Huang R, Hoy J, Bloch M, et al
    Prevalence of self-reported comorbidities in HIV positive and HIV negative men who have sex with men over 55 years-The Australian Positive & Peers Longevity Evaluation Study (APPLES).
    PLoS One. 2017;12:e0184583.
    >> Share

  44. KYAW KWY, Oo MM, Kyaw NTT, Phyo KH, et al
    Low mother-to-child HIV transmission rate but high loss-to-follow-up among mothers and babies in Mandalay, Myanmar; a cohort study.
    PLoS One. 2017;12:e0184426.
    >> Share

  45. HOLLOWAY IW, Traube DE, Schrager SM, Tan D, et al
    Psychological distress, health protection, and sexual practices among young men who have sex with men: Using social action theory to guide HIV prevention efforts.
    PLoS One. 2017;12:e0184482.
    >> Share

  46. KAYAMBA V, Shibemba A, Zyambo K, Heimburger DC, et al
    High prevalence of gastric intestinal metaplasia detected by confocal laser endomicroscopy in Zambian adults.
    PLoS One. 2017;12:e0184272.
    >> Share

  47. MASIA M, Padilla S, Moreno S, Barber X, et al
    Prediction of long-term outcomes of HIV-infected patients developing non-AIDS events using a multistate approach.
    PLoS One. 2017;12:e0184329.
    >> Share

  48. NGUYEN KA, Peer N, de Villiers A, Mukasa B, et al
    Optimal waist circumference threshold for diagnosing metabolic syndrome in African people living with HIV infection.
    PLoS One. 2017;12:e0183029.
    >> Share

  49. SOERIA-ATMADJA S, Osterberg E, Gustafsson LL, Dahl ML, et al
    Genetic variants in CYP2B6 and CYP2A6 explain interindividual variation in efavirenz plasma concentrations of HIV-infected children with diverse ethnic origin.
    PLoS One. 2017;12:e0181316.
    >> Share

    PLoS Pathog

  50. NAKANO Y, Misawa N, Juarez-Fernandez G, Moriwaki M, et al
    Correction: HIV-1 competition experiments in humanized mice show that APOBEC3H imposes selective pressure and promotes virus adaptation.
    PLoS Pathog. 2017;13:e1006606.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016